For: | Korphaisarn K, Pongpaibul A, Limwongse C, Roothumnong E, Klaisuban W, Nimmannit A, Jinawath A, Akewanlop C. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. World J Gastroenterol 2015; 21(3): 926-934 [PMID: 25624727 DOI: 10.3748/wjg.v21.i3.926] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i3/926.htm |
Number | Citing Articles |
1 |
Xiangyan Zhang, Wenwen Ran, Jie Wu, Hong Li, Huamin Liu, Lili Wang, Yujing Xiao, Xiaonan Wang, Yujun Li, Xiaoming Xing. Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China. PeerJ 2018; 6: e4341 doi: 10.7717/peerj.4341
|
2 |
João Cortez Pinto, Isadora Rosa, Catarina Martins, Inês Marques, João Pereira da Silva, Ricardo Fonseca, João Freire, António Dias Pereira. Colon Adenocarcinoma Stage IIA—Can We Predict Relapse?. Journal of Gastrointestinal Cancer 2020; 51(1): 116 doi: 10.1007/s12029-019-00218-9
|
3 |
Jiao Yang, Xiang lin Du, Shu ting Li, Bi yuan Wang, Yin ying Wu, Zhe ling Chen, Meng Lv, Yan wei Shen, Xin Wang, Dan feng Dong, Dan Li, Fan Wang, En xiao Li, Min Yi, Jin Yang, Hemant Kumar Bid. Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients. PLOS ONE 2016; 11(12): e0167540 doi: 10.1371/journal.pone.0167540
|
4 |
Lauren C. Bylsma, Christina Gillezeau, Tamer A. Garawin, Michael A. Kelsh, Jon P. Fryzek, Laura Sangaré, Kimberly A. Lowe. Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta‐analysis. Cancer Medicine 2020; 9(3): 1044 doi: 10.1002/cam4.2747
|
5 |
Dongdong Huang, Wenjie Sun, Yuwei Zhou, Peiwei Li, Fang Chen, Hanwen Chen, Dajing Xia, Enping Xu, Maode Lai, Yihua Wu, Honghe Zhang. Mutations of key driver genes in colorectal cancer progression and metastasis. Cancer and Metastasis Reviews 2018; 37(1): 173 doi: 10.1007/s10555-017-9726-5
|
6 |
Zheng Wang, Xiaoli Tang, Xiaoqing Wu, Meiyuan Yang, Daorong Wang. Mismatch repair status between primary colorectal tumor and metastatic tumor, a retrospective consistent study. Bioscience Reports 2019; 39(12) doi: 10.1042/BSR20190730
|
7 |
Nunthawut Chat-Uthai, Pichpisith Vejvisithsakul, Sutthirat Udommethaporn, Puttarakun Meesiri, Chetiya Danthanawanit, Yannawan Wongchai, Chinachote Teerapakpinyo, Shanop Shuangshoti, Naravat Poungvarin, John Souglakos. Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues. PLOS ONE 2018; 13(6): e0198795 doi: 10.1371/journal.pone.0198795
|
8 |
Chuchu Zhao, Saisai Li, Menghuang Zhao, Haiyan Zhu, Xueqiong Zhu. Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy. Archives of Gynecology and Obstetrics 2018; 297(1): 153 doi: 10.1007/s00404-017-4563-x
|
9 |
Mahmood Moosazadeh, Azita sadough, Mahdi Afshari, Saeed barzegari, Ghasem Janbabaee, Reza Tabrizi, Maryam Akbari, Reza Alizadeh‐Navaei, Akbar Hedayatizadeh‐Omran, Fereshteh Rostami-Maskopaee. Prevalence of BRAF gene mutation in samples of primary and metastatic colorectal cancer: A meta‐analysis. European Journal of Cancer Care 2019; 28(6) doi: 10.1111/ecc.13160
|
10 |
James W. T. Toh, Kevin Phan, Faizur Reza, Pierre Chapuis, Kevin J. Spring. Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis. International Journal of Colorectal Disease 2021; 36(8): 1573 doi: 10.1007/s00384-021-03874-1
|
11 |
Chong Lai, Wenjie Sun, Xiaosheng Wang, Xingyu Xu, Mengyuan Li, Dongdong Huang, Enping Xu, Maode Lai, Honghe Zhang. RNF43 frameshift mutations contribute to tumourigenesis in right-sided colon cancer. Pathology - Research and Practice 2019; 215(8): 152453 doi: 10.1016/j.prp.2019.152453
|
12 |
George Kunnackal John, Vipin Das Villgran, Christine Caufield-Noll, Francis M. Giardiello. Comparison of universal screening in major lynch-associated tumors: a systematic review of literature. Familial Cancer 2022; 21(1): 57 doi: 10.1007/s10689-020-00226-w
|
13 |
Cong-Min Zhang, Jin-Feng Lv, Liang Gong, Lin-Yu Yu, Xiao-Ping Chen, Hong-Hao Zhou, Lan Fan. Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer. International Journal of Environmental Research and Public Health 2016; 13(9): 892 doi: 10.3390/ijerph13090892
|
14 |
Kanjana Sukhokanjanachusak, Ananya Pongpaibul, Akarin Nimmannit, Charuwan Akewanlop, Krittiya Korphaisarn. Clinicopathological Characteristics and Outcome of Adolescent and Young Adult-Onset Microsatellite Stable Colorectal Cancer Patients. Journal of Adolescent and Young Adult Oncology 2021; 10(5): 573 doi: 10.1089/jayao.2020.0144
|
15 |
Na Li, Honghe Xiao, Jiangli Shen, Ximin Qiao, Fenjuan Zhang, Weibo Zhang, Yuan Gao, Yue Dong Liu. SELE gene as a characteristic prognostic biomarker of colorectal cancer. Journal of International Medical Research 2021; 49(4) doi: 10.1177/03000605211004386
|
16 |
George Kunnackal John, Vipin Das Villgran, Christine Caufield-Noll, Francis Giardiello. Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas. Familial Cancer 2021; 20(2): 145 doi: 10.1007/s10689-020-00206-0
|
17 |
Krittiya Korphaisarn, Kanjana Sukhokanjanachusak, Ananya Pongpaibul, Vitoon Chinswangwatanakul, Charuwan Akewanlop. Loss of CDX‐2 expression is an independent poor prognostic biomarker in patients with early‐stage deficient mismatch repair colorectal cancer. Asia-Pacific Journal of Clinical Oncology 2022; 18(3): 249 doi: 10.1111/ajco.13612
|
18 |
Shilpi Saxena, V. Srinivas, Prabal Deb, Deep Kumar Raman, Rajat Jagani. A study of BRAF mutation in colorectal carcinoma in Indian population. Journal of Cancer Research and Therapeutics 2018; 14(6): 1403 doi: 10.4103/jcrt.JCRT_26_17
|
19 |
Huabin Hu, Zehua Wu, Chao Wang, Yan Huang, Jianwei Zhang, Yue Cai, Xiaoyu Xie, Jianxia Li, Cailu Shen, Weiwei Li, Jiayu Ling, Xuehu Xu, Yanhong Deng. Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.579478
|
20 |
C. Yan, S. Liu, X. Pan, G. Chen, W. Ge, W. Guan, S. Liu, M. Li, J. He, Z. Zhou. Role of intravoxel incoherent motion MRI in preoperative evaluation of DNA mismatch repair status in rectal cancers. Clinical Radiology 2019; 74(10): 814.e21 doi: 10.1016/j.crad.2019.07.004
|
21 |
Tasuku Mariya, Terufumi Kubo, Yoshihiko Hirohashi, Junko Yanagawa, Yuta Tabuchi, Kazuhiko Matsuo, Kiyoshi Furumura, Rena Morita, Munehide Nakatsugawa, Takayuki Kanaseki, Tomohide Tsukahara, Tadashi Hasegawa, Tsuyoshi Saito, Toshihiko Torigoe. Less correlation between mismatch repair proteins deficiency and decreased expression of HLA class I molecules in endometrial carcinoma: a different propensity from colorectal cancer. Medical Molecular Morphology 2021; 54(1): 14 doi: 10.1007/s00795-020-00254-6
|